The effect of valproic acid on blood loss in patients with cerebral palsy

Journal of Pediatric Orthopaedics

Volumn 19, Issue 6, 1999, Pages 792-795

  Chambers, Henry G ^a,b   Weinstein, Craig H ^a   Mubarak, Scott J ^a   Wenger, Dennis R ^a   Silva, Patricia D ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b Pediat Orthoped and Scoliosis Ctr   (United States)

Author keywords

Blood loss; Cerebral palsy; Valproic acid

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CELL COUNT; BLOOD TRANSFUSION; CEREBRAL PALSY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SCOLIOSIS; SEIZURE; SPINE FUSION; THROMBOCYTE;

EID: 0032740508     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01241398-199911000-00018     Document Type: Article

References (35)

1. Allarakhia IN, Garofalo EA, Komarynski MA, Robertson PL. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study. Pediatr Neurol 1996;14:303-7.
2. Allen BL Jr, Ferguson RL. The Galveston technique for L rod instrumentation of the scoliotic spine. Spine 1982;7:276-84.
3. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991.
4. Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC. Valproic acid and immune thrombocytopenia. Arch Dis Child 1982; 57:681-4.
5. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 1982;23:693-720.
6. Delgado MR, Riela AR, Mills J, Browne R, Roach ES. Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 1994;9:311-4.
7. Gidal B, Spencer N, Maly M, et al. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration. Neurology 1994;44:1418-22.
8. Hackett T, Kelton JG, Powers P. Drug-induced platelet destruction. Semin Thromb Hemost 1982;8:116-37.
9. Hirose Y, Konda S. Depakene-induced intravascular hemolysis and pure red cell aplasia. Nippon Ketsueki Gakkai Zasshi 1984; 47:1366-70.
10. Hoffman LM. Sodium valproate and thrombocytopenia [Letter]. Can Med Assoc J 1982;126:358-9.
11. Isom JB. On the toxicity of valproic acid [Editorial]. Am J Dis Child 1984;138:901-3.
12. Jensen NB, Storm K. [Neutropenia during treatment with valproate]. Ugeskr Laeger 1987;149:664.
13. Jimenez-Rodriguezvila M, Caro-Patãon A, Conde M, et al. Side-effects of sodium valproate, mainly related to its hepatic and pancreatic toxicity. Int J Clin Pharmacol Res 1986;6:217-24.
14. Kapetonovic I, Kupferberg HJ, Porter RJ, Penry JK. Valproic acid-phenobarbital interaction: a systematic study using stable isotopically labeled phenobarbital in an epileptic patient. In: Johannessen SI, Morselli PL, Pippenger CE, Richens A, Schmidt D, Meinardi H, eds. Anti-epileptic therapy advances in drug monitoring. New York: Raven Press, 1980:373-80.
15. Kerèanen T, Sivenius J. Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. Acta Neurol Scand Suppl 1983;97:69-80.
16. Koch-Weser J, Browne TR. Drug therapy: valproic acid. N Engl J Med 1980;302:661-6.
17. Loiseau P. [Sodium valproate, platelet dysfunction and bleeding (author's transl)]. Nouv Presse Med 1981;10:3789-90.
18. Loiseau P. Sodium valproate, platelet dysfunction, and bleeding. Epilepsia 1981;22:141-6.
19. MacDougall LG. Pure red cell aplasia associated with sodium valproate therapy. JAMA 1982;247:53-4.
20. Majer RV, Green PJ. Neonatal afibrinogenaemia due to sodium valproate [Letter]. Lancet 1987;2:740-1.
21. Morris N, Barr RD, Pai KR, Kelton JG. Valproic acid and thrombocytopenia. Can Med Assoc J 1981;125:63-4.
22. Nathan D, Guillon JL, Chevallier B, Gallet JP. [Thrombopenia and erythroblastopenia in a 1-month-old infant treated with valproate]. Ann Pediatr (Paris) 1987;34:149-50.
23. Neophytides AN, Nutt JG, Lodish JR. Thrombocytopenia associated with sodium valproate treatment. Ann Neurol 1979;5:389-90.
24. Patel CC, Church S, Reilly KM. Valproic acid and thrombocytopenia: case report. J Ky Med Assoc 1982;80:213-5.
25. Sandler RM, Bevan PC, Roberts GE, et al. Interaction between sodium valproate and platelets: a further study. Br Med J 1979;2: 1476.
26. Sandler RM, Emberson C, Roberts GE, Voak D, Darnborough J, Heeley AF. IgM platelet autoantibody due to sodium valproate. Br Med J 1978;2:1683-4.
27. Schmidt D. Adverse effects of valproate. Epilepsia 1984;25(suppl 1):S44-9.
28. Schreiber WE, Schmer G. Application of mechanical impedance measurements to the study of dysfibrinogens. J Lab Clin Med 1984;104:494-500.
29. Smith FR, Boots M. Sodium valproate and bone marrow suppression. Ann Neurol 1980;8:197-9.
30. Sussman NM, McLain LW Jr. A direct hepatotoxic effect of valproic acid. JAMA 1979;242:1173-4.
31. Terui T, Ktda K, Mitani T, et al. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration -with statistical analysis of 33 cases administrated sodium valproate]. Rinsho Ketsueki 1987;28:865-71.
32. Torelli D, Galeone D, Lamontanara G. Several hematic parameters in children treated with sodium valproate. Acta Neurol (Napoli) 1982;4:460-3.
33. Watts RG, Emanuel PD, Zuckerman KS, Howard TH. Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis. J Pediatr 1990;117:495-9.
34. Winter SL, Kriel RL, Novacheck TF, Luxenberg MG, Leutgeb VJ, Erickson PA. Perioperative blood loss: the effect of valproate. Pediatr Neurol 1996;15:19-22.
35. Wyllie E, Wyllie R, Cruse RP, Erenberg G, Rothner AD. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984; 138:912-4.